about
BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP aut...
Read More
1.34
0.03
(2.29%)
38,982
XNAS Volume
XNAS 23 Jan, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Bearish
BioCardia Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..